Lewis, R. v. Reading Hosp.

2025 Pa. Super. 191
Superior Court of Pennsylvania·Decided September 2, 2025·No. 986 MDA 2024·Published

Opinion

2025 PA Super 191

RONALD LEWIS : IN THE SUPERIOR COURT OF : PENNSYLVANIA

:

v. :

:

:

READING HOSPITAL, ROBERT Q. : LUO, M.D., AND TOWER HEALTH : MEDICAL GROUP : No. 986 MDA 2024 :

Appellants :

Appeal from the Order Entered June 6, 2024 In the Court of Common Pleas of Berks County Civil Division at No(s):

22 13056

BEFORE: BOWES, J., OLSON, J., and STABILE, J. OPINION BY STABILE, J.: FILED SEPTEMBER 02, 2025 In this medical malpractice action, Reading Hospital, Robert Q. Luo, M.D., Tower Health Medical Group (defendants/Appellants) were found liable for the injuries sustained by Ronald Lewis (plaintiff/Appellee) after he underwent vascular surgery in 2021. A jury found that Appellants had negligently deviated from the standard of care when providing post-operative treatment. Appellee was awarded $869,000 in damages. Appellants now contend that the verdict must be vacated because the trial court erred in (1) excluding their expert witness on causation; (2) failing to grant a mistrial after Appellee’s counsel told the jury that the defense was unable to retain an expert on causation; (3) allowing Appellee’s expert witness to testify that he had once been retained in an unrelated case as an expert by Reading Hospital; and (4) giving an instruction and verdict form to the jury which equated the

negligence element of factual cause with an “increased risk of harm.” Finding merit in Appellants’ second and fourth claims, we vacate the order on review and remand the case for a new trial on those grounds.

On April 6, 2021, Appellee, at the age of 72, underwent open vascular surgery at Reading Hospital for the purpose of repairing abdominal aortic aneurisms. Dr. Luo performed the surgery, and soon after it was completed, Appellee reported severe pain, swelling, and discoloration in his left foot.

It would soon become evident that Appellee’s post-surgery symptoms were due to a lack of blood flow (ischemia). One likely cause of that type of ischemic injury was the loosening of plaque (micro-emboli) from Appellee’s diseased arteries during his vascular surgery.

Rather than treat the ischemic injury immediately after the manifestation of Appellee’s symptoms, Dr. Luo opted to monitor him to better ascertain whether and to what extent tissue from his foot would have to be removed. Dr. Luo believed that there was no viable surgical or medicinal means of remedying the underlying ischemic injury. Appellee was only prescribed an antibiotic medication to address a possible bacterial infection resulting from an apparent burn on Appellee’s left foot which was unrelated to the vascular surgery.1 Within three weeks of Appellee’s surgery, his left foot developed

gangrene and had to be amputated. Appellee filed a complaint on September

1 Appellee disputed that he had a burn injury on his left foot at that time, arguing that Appellants had misdiagnosed the burn as a sign of ischemia.

6, 2022, alleging that Dr. Luo had been negligent in treating his post-surgery ischemic injury, resulting in the amputation. Reading Hospital and Tower Health Medical Group were alleged to be vicariously liable for Dr. Luo’s negligence. Appellants timely filed an answer and new matter. Appellee then filed a reply to new matter.

One of the central trial issues was whether Appellants failed to treat Appellee in accordance with the applicable standard of medical care. Prior to trial, Appellants produced a report from their expert, Herrick Wun, M.D., a board-certified vascular surgeon. Dr. Wun obtained an undergraduate degree from Yale University; medical degrees from the New York University School of Medicine; and a professorship at the Weill Cornell Medical College, where he specialized in vascular medicine. He also worked as an attending physician at the Weill Cornell Medical Center and maintained an active clinical practice.

In his report, Dr. Wun opined that there was no surgical option for removing the clots in Appellee’s arteries; he further opined that a blood thinning medication (anticoagulant) would not have prevented the need to amputate Appellee’s foot:

Anticoagulation is not without its risks and an endpoint is needed once started. There are no guidelines for anticoagulation when the source is atheroembolic disease. In fact, some studies have shown a worse outcome when anticoagulation is given for these situations. Moreover, anticoagulation was not appropriate here because of the risks of bleeding after this open procedure.

Expert Report of Herrick Wun, M.D., December 14, 2023, at 3.

The opinion of Dr. Wun differed from that of Appellee’s expert, Timothy Wu, M.D., a vascular surgeon who opined in his own report that an anticoagulant should have been administered as soon as Appellee’s symptoms manifested in his foot. See Expert Report of Timothy Wu, M.D., 10/25/2023, at 6.2 Dr. Wu stated that the failure to give Appellee such medication breached the standard of care, increased the risk of harm, and played a role in causing the need for the foot’s amputation. See id.

Appellee filed a motion in limine on February 23, 2024, to preclude Appellants’ expert, Dr. Wun, from relying on the unidentified medical literature referred to in his report. On March 12, 2024, the trial court entered an order compelling Dr. Wun to name the studies he had relied upon.

Ten days later, on March 22, 2024, Dr. Wun submitted a supplemental report which failed to comply with the trial court’s directive. He cited no studies which supported his opinion that anticoagulants may produce a “worse outcome.” Supplemental Expert Report of Herrick Wun, M.D., 3/22/2024, at 1. Instead, Dr. Wun stated that no particular studies had “come to mind,” and that it was nevertheless his opinion, “as well as [that of] other experts[,] that anticoagulation is not beneficial.” Id.

2 Appellants and Appellee each retained an expert in the field of hematology.

Appellee produced a report by Samuel Berkman, M.D., who opined that an anticoagulant medication should have been given to Appellee; Appellants’ hematology expert, Henry Rinder M.D., opined that an anticoagulant would not have improved Appellee’s condition.

On March 27, 2024, Appellee again moved to limit Dr. Wun’s testimony as a sanction for flouting the trial court’s prior order. The trial court held a hearing on the motion, and on April 2, 2024, the trial court entered an order granting Appellee’s motion in limine to preclude Dr. Wun from testifying in reliance on any medical studies. The trial court heard further argument from the parties on April 9, 2024, as to whether Dr. Wun would be precluded from testifying at all as an expert witness. The trial court then entered an order on that date precluding Dr. Wun from giving any expert opinions.

A few days after that latter order, Appellants moved for reconsideration, submitting a second supplemental expert report by Dr. Wun, dated April 11, 2024. Disavowing the previously referenced, but unnamed, medical studies and opinions of other experts, Dr. Wun stated that he was relying only on his own “education, training, and clinical experience”:

It is my opinion, based on my education, training, and clinical experience as a vascular surgeon and upon review of the medical records, documents provided, and facts in this case that anticoagulation is not appropriate or beneficial in situations like Mr. Lewis'. I reached this opinion without relying on opinions of any other experts or any specific medical studies. These opinions are rendered to a reasonable degree of medical certainty.

Memorandum of Law in Support of Motion for Reconsideration of the April 2 and 9, 2024 Orders Preluding Expert Testimony by Dr. Wun, 4/12/2024, at Exhibit D (emphasis added).

Free access — add to your briefcase to read the full text and ask questions with AI

Lewis, R. v. Reading Hosp., 2025 Pa. Super. 191 (Pa. Ct. App. 2025).

2025 Pa. Super. 191 (Lewis, R. v. Reading Hosp.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Woods v. Brumlop
377 P.2d 520 (New Mexico Supreme Court, 1962)
Carrozza v. Greenbaum
866 A.2d 369 (Superior Court of Pennsylvania, 2004)
Smith v. Paoli Memorial Hospital
885 A.2d 1012 (Superior Court of Pennsylvania, 2005)
Commonwealth v. Jones
668 A.2d 491 (Supreme Court of Pennsylvania, 1995)
Grady v. Frito-Lay, Inc.
839 A.2d 1038 (Supreme Court of Pennsylvania, 2003)
Toogood v. Rogal
824 A.2d 1140 (Supreme Court of Pennsylvania, 2003)
Primavera v. Celotex Corp.
608 A.2d 515 (Superior Court of Pennsylvania, 1992)
Siegal v. Stefanyszyn
718 A.2d 1274 (Superior Court of Pennsylvania, 1998)
Mitzelfelt v. Kamrin
584 A.2d 888 (Supreme Court of Pennsylvania, 1990)
Winschel v. Jain
925 A.2d 782 (Superior Court of Pennsylvania, 2007)
Miller v. Brass Rail Tavern, Inc.
664 A.2d 525 (Supreme Court of Pennsylvania, 1995)
Millen v. Miller
308 A.2d 115 (Superior Court of Pennsylvania, 1973)
Hamil v. Bashline
392 A.2d 1280 (Supreme Court of Pennsylvania, 1978)
Hickman v. Fruehauf Corp.
563 A.2d 155 (Supreme Court of Pennsylvania, 1989)
Halper v. Jewish Family & Children's Service
963 A.2d 1282 (Supreme Court of Pennsylvania, 2009)
Sutherland v. Monongahela Valley Hospital
856 A.2d 55 (Superior Court of Pennsylvania, 2004)
Feden v. Consolidated Rail Corp.
746 A.2d 1158 (Superior Court of Pennsylvania, 2000)
Corrado v. Thomas Jefferson University Hospital
790 A.2d 1022 (Superior Court of Pennsylvania, 2001)
Wagner v. Anzon, Inc.
684 A.2d 570 (Superior Court of Pennsylvania, 1996)
Kaminski v. Employers Mutual Casualty Co.
487 A.2d 1340 (Supreme Court of Pennsylvania, 1985)